C-SSRS: Columbia-Suicide Severity Rating Scale

Foundational Context

The Columbia-Suicide Severity Rating Scale (C-SSRS) is the FDA-recommended criterion standard tool for suicide risk assessment. Developed by Posner et al. (2011), it is used globally in clinical practice, research, and crisis intervention.

The C-SSRS is unique in that it tracks suicidal ideation and behavior over time, providing a standardized way to monitor clinical change during high-risk periods. It is endorsed by the CDC, NIH, and World Health Organization.

What the Assessment Measures

The C-SSRS measures the full spectrum of suicidal ideation and behavior:

1. Ideation Severity (Items 1–5): Ranges from "wish to be dead" to "active ideation with specific plan and intent."
2. Ideation Intensity: Frequency, duration, controllability, deterrents, and reasons for ideation.
3. Suicidal Behavior: Actual attempts, interrupted attempts, aborted attempts, and preparatory acts.
4. Lethality: Actual medical damage from attempts.

Interpretation Guidelines

The C-SSRS stratifies risk based on endorsed items:

• Low Risk: Wish to be dead or passive ideation without method/intent/plan (Items 1–2).
• Moderate Risk: Active ideation with method, but no specific plan or intent (Item 3).
• High Risk: Suicidal ideation with specific plan, intent (Items 4–5), or recent preparatory behavior/attempts.

Critical Action: Any "Yes" response to items 4 or 5, or any recent suicidal behavior, requires immediate safety intervention and clinical escalation.

Administration Considerations

• Interviewer: Requires clinician administration; not a self-report tool.
• Time: Full version takes 10–15 minutes; Screener version takes 2–3 minutes.
• Age: Validated for ages 12 and older; separate pediatric versions are available.
• Protocol: Direct questioning does not increase suicide risk and is essential for safety.

Psychometric Properties

• Reliability: Excellent inter-rater reliability (> 0.90).
• Validity: Strong predictive validity for future suicide attempts.
• Endorsement: Required assessment in FDA-regulated clinical trials.

Limitations

• Does not replace clinical judgment or the need for a comprehensive safety plan.
• Reliant on the respondent's honesty and the interviewer's rapport-building.

References

Posner, K., Brown, G. K., Stanley, B., et al. (2011). The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266-1277.

Additional Context

The criterion standard for suicide risk assessment. Evidence-based, simple to use, and validated across diverse populations and settings.

Risk Classification

Clinical actions based on suicide risk severity

Critical Safety Protocol

High risk requires immediate action: Do NOT leave patient alone. Call 988 Suicide & Crisis Lifeline, contact emergency services (911), or transport to emergency department. Complete safety planning, remove means, and engage support system. Document all interventions.

Assessment Domains

Four core areas evaluated by the C-SSRS

C-SSRS Screening Tool

Interactive screener for clinical training purposes only

⚠️ For educational purposes only. Not a substitute for trained clinical assessment.

Risk Severity Guide

Visual representation of C-SSRS risk stratification

Documenting C-SSRS results in clinical notes?

C-SSRS ideation type and intensity belong in the Objective section; risk level and safety plan belong in the Assessment and Plan sections. See our SOAP notes guide and progress notes guide.

C-SSRS vs Other Suicide Risk Assessments

Comparing the Columbia Suicide Severity Rating Scale to other validated suicide risk screening tools.

C-SSRS vs Other Tools

C-SSRS vs ASQ (Ask Suicide-Screening Questions), C-SSRS vs P4 Screener, C-SSRS vs SBQ-R (Suicide Behaviors Questionnaire-Revised).

Choosing the Right Suicide Risk Assessment

Use C-SSRS When:

• • Need detailed risk stratification
• • Tracking suicidality over time (measurement-based care)
• • Emergency or crisis settings
• • Required for clinical documentation
• • Want FDA/NIH-endorsed tool

Consider Alternatives When:

• • ASQ: Pediatric medical settings, very brief screening
• • P4: Want to integrate clinical judgment, assess protective factors
• • SBQ-R: Research setting, population screening

Clinical Note: All suicide risk assessments should be followed by clinical interview and safety planning when risk is identified. No screening tool replaces clinical judgment.

Explore More Tools

Crisis Resources

If you or someone you know is in crisis, please reach out promptly. Help is available 24/7.